ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.71
0.61%
US Dollar vs AUD
1.49455
-0.15%
Bitcoin
66,572.29
2.04%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cogent Biosciences Inc (COGT)

  7. Cogent Biosciences Inc (COGT) News

COGT

Cogent Biosciences (COGT)

Cogent Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:COGT
DateTimeSourceHeadlineSymbolCompany
07/05/202422:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COGTCogent Biosciences Inc
07/05/202422:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COGTCogent Biosciences Inc
07/05/202422:00GlobeNewswire Inc.Cogent Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:COGTCogent Biosciences Inc
09/04/202423:00GlobeNewswire Inc.Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 InhibitorNASDAQ:COGTCogent Biosciences Inc
27/02/202408:34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:COGTCogent Biosciences Inc
27/02/202401:13Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:COGTCogent Biosciences Inc
27/02/202400:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COGTCogent Biosciences Inc
27/02/202400:00GlobeNewswire Inc.Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:COGTCogent Biosciences Inc
23/02/202406:30GlobeNewswire Inc.Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic MastocytosisNASDAQ:COGTCogent Biosciences Inc
17/02/202410:55Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:COGTCogent Biosciences Inc
17/02/202410:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COGTCogent Biosciences Inc
15/02/202408:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:COGTCogent Biosciences Inc
15/02/202404:51Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:COGTCogent Biosciences Inc
15/02/202400:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COGTCogent Biosciences Inc
14/02/202423:00GlobeNewswire Inc.Cogent Biosciences Announces Oversubscribed $225 Million Private PlacementNASDAQ:COGTCogent Biosciences Inc
10/02/202408:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:COGTCogent Biosciences Inc
06/02/202401:00GlobeNewswire Inc.Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual MeetingNASDAQ:COGTCogent Biosciences Inc
26/01/202408:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COGTCogent Biosciences Inc
26/01/202408:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COGTCogent Biosciences Inc
26/01/202408:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COGTCogent Biosciences Inc
26/01/202408:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COGTCogent Biosciences Inc
10/01/202400:00GlobeNewswire Inc.Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted TherapeuticsNASDAQ:COGTCogent Biosciences Inc
05/01/202408:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COGTCogent Biosciences Inc
03/01/202400:00GlobeNewswire Inc.Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:COGTCogent Biosciences Inc
12/12/202300:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COGTCogent Biosciences Inc
11/12/202323:55GlobeNewswire Inc.Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)NASDAQ:COGTCogent Biosciences Inc
10/12/202305:30GlobeNewswire Inc.Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)NASDAQ:COGTCogent Biosciences Inc
08/12/202301:00GlobeNewswire Inc.Cogent Biosciences Presents New Preclinical Data Highlighting Potential Best-in-Class Potency and Selectivity of ErbB2 and PI3Kα inhibitor programs at the San Antonio Breast Cancer SymposiumNASDAQ:COGTCogent Biosciences Inc
05/12/202300:00GlobeNewswire Inc.Cogent Biosciences to Host Investor Webcast on December 11, 2023 at 8:00 AM ET to Review Clinical Data Being Presented at American Society of Hematology (ASH) Annual MeetingNASDAQ:COGTCogent Biosciences Inc
30/11/202300:00GlobeNewswire Inc.Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer SymposiumNASDAQ:COGTCogent Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:COGT

Your Recent History

USOTC
CANQF
Canaquest Medical (PK)
UPBT
FORBTC
The Force Token [ForTube]
EU
AUUJL
Amundi Finance Emissions...
NASDAQ
CCSI
Concensus Cloud Solutions
BINA
HIFIETH
Hifi Finance
TSX
ESPX.B
Evolve S&P 500 Enhanced ...
BIT
UC7Z18
Unicredit Bank
COIN
BUSDEUR
BMF
PTXUSDC
PTXUSDC
DGFX
BPXETH
BispexToken
LSE
0KEQ
Pvh
COIN
DCNGBP
Dentacoin
USOTC
AEOXF
Aeroports de Paris Adp (PK)
USOTC
FSPKF
Fisher and Paykel Health... (PK)
NASDAQ
FEAIQX
High Dividend Equity All...
GATE
GSUSDT
Gen Shards
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved